Sexual dysfunction is a common consequence of cancer treatment, affecting at least half of
men and women treated for pelvic malignancies and over a quarter of people with other …

Purpose The purpose of this systematic review was to identify, with supporting evidence, the
impact of cancer and its treatment on the sexual function of adolescents and young adults …

Background Prevalence of erectile dysfunction (ED) in male survivors of cancer across
cancer types has not been systematically analysed. Aim To estimate the prevalence of ED in …

Purpose: To examine and characterize the psychosocial and health service needs of adult
leukemia and lymphoma survivors who had completed active treatment within the past 4 …

Purpose Sexual function in male lymphoma survivors was examined and compared with that
of age-matched controls. Patients and Methods This cross-sectional study included serum …

Background With improved survival in patients with lymphoma, long-term toxicity and quality
of life (QoL), including sexual health, have become increasingly important. Aim We aimed to …

Introduction Unambiguous data on sexual dysfunction after Hodgkin lymphoma (HL)
treatment are scarce. Aims To form a baseline in this area, we compared patient-reported …

A multicenter, observational, cross-sectional study was conducted to assess the sexual
function of male survivors of hematological malignancy treated by autologous hematopoietic …

Advancements in lymphoma treatment have increased the number of long-term survivors
who may experience late effects such as impaired sexual function and testosterone …

Although the extent of SD among AYACP is widely recognized, oncological clinicians rarely
address SD in their routine practice, lacking a clear approach of interdisciplinary diagnostic …